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Secreted semaphorins are a large group of extracel-
lular proteins involved in a variety of processes during
development, including neuronal migration and axon
guidance. We screened a peptoid combinatorial
library to search for semaphorin 3A inhibitors, and
identified a peptoid (SICHI: semaphorin Induced
chemorepulsion inhibitor) that blocks semaphorin
3A-chemorepulsion and growth-cone collapse in
axons at millimolar concentrations. SICHI inhibits
the binding of semaphorin 3A to its receptor complex
(neuropilin 1/plexin A1) and semaphorin 3A-induced
phosphorylation of GSK3. Chemorepulsion induced
by semaphorin 3F or netrin 1 is not blocked by SICHI.
We also show that SICHI promotes neural regenera-
tion of damaged axons. We suggest that SICHI,
a selective inhibitor of semaphorin 3A, is of thera-
peutic interest for approaches aimed at promoting
axonal regeneration and brain repair.
INTRODUCTION
Class III semaphorins are vertebrate-secreted proteins (Ander-
son et al., 2003) with crucial roles during the development of
the nervous system. Most secreted semaphorins mediate
axon-growth inhibition at a distance, thereby promoting axonal
chemorepulsion in both the central and peripheral nervous
systems (CNS and PNS, respectively) (Kolodkin et al., 1993;
Luo et al., 1995; Puschel et al., 1995; Van Vactor and Lorenz,
1999). Class III semaphorins act via a receptor complex formed
by neuropilins 1/2 as the ligand binding subunit and A-plexins
(Deo et al., 2004) as the signal-transducing subunit (Chen
et al., 1997, 2000; Feiner et al., 1997; Giger et al., 1998, 2000;
He and Tessier-Lavigne, 1997; Kitsukawa et al., 1997; Kolodkin
et al., 1997; Nakamura et al., 1998; Renzi et al., 1999; Takahashi
et al., 1998). Genetic studies using mutations for either sema-
phorin or receptor genes, and other experimental studies, indi-
cate a fundamental role of class III semaphorins in the develop-
ment of neural connections. Class III semaphorins alsoChemistry & Biology 16participate in tissue patterning, cell migration, tumor biology,
and heart formation (Che´dotal et al., 2005; Klagsbrun et al.,
2002; Kruger et al., 2005; Pasterkamp and Verhaagen, 2001).
Neuropilin 1 (Np1), a receptor of semaphorin 3A (Sema3A), is
also a coreceptor of VEGFR2, whichmediates vascular develop-
ment (Pan et al., 2007; Soker et al., 1998; Suchting et al., 2006).
Thus, neuropilins and semaphorins play a role in angiogenesis,
both in normal development and in pathological conditions
(Guttmann-Raviv et al., 2006; Suchting et al., 2006). Further-
more, Sema3A, and its receptors Np1 and PlexA1 (as well as
other semaphorins), have been implicated in tumor progression
and metastasis (Guttmann-Raviv et al., 2006; Staton et al., 2007;
Suchting et al., 2006; Torres-Va´zquez et al., 2004).
In the adult CNS, severed axons fail to regenerate beyond the
lesion site, in contrast to those in the peripheral or embryonic
nervous system. The failure of axon regeneration is mainly attrib-
utable to the environment encountered by injured axons. Inhibi-
tion is associated with myelin proteins, such as Nogo-A and
MAG, and molecules in the glial scar at the lesion site, including
proteoglycans (Bradbury et al., 2002; Bregman et al., 2002; Fon-
toura et al., 2004; Mingorance et al., 2005; Schnell and Schwab,
1990). However, recent studies that genetically target these
molecules or use blockers have shown only modest regenera-
tion, indicating that other inhibitory signals contribute to the
failure of axonal regrowth (Bregman et al., 1995; Fontoura et al.,
2004; Schmidt and Strittmatter, 2007). It has also been shown
that class III semaphorins, including Sema3A, are expressed in
the adult brain and spinal cord, where they are regulated by
synaptic activity (Pasterkamp and Verhaagen, 2001), and after
lesions (De Winter et al., 2002). Overexpression of Sema3A has
been demonstrated after anisomorphic injury of the corticospinal
tract (DeWinter et al., 2002), and in lesions of the lateral olfactory
tract or the entorhino-hippocampal pathway (Pasterkamp et al.,
1999). The participation of secreted semaphorins in the glial
scar, together with that of other inhibitors of axonal growth, has
recently been demonstrated in vitro (Shearer et al., 2003).
We attempted to identify small molecules that block sema-
phorin/neuropilin functions by screening amixture-basedcombi-
natorial library of over 10,000 N-alkylglycines trimers (peptoids)
(Humet et al., 2003). We searched for products that could block
Sema3A-induced axonal chemorepulsion using a tissue-explant
assay. We identified an active peptoid, which we then tested in, 691–701, July 31, 2009 ª2009 Elsevier Ltd All rights reserved 691
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Inhibitors of Sema3A Chemorepulsionseveral functional situations such as axonal chemorepulsion,
growth-cone collapse, or GSK-3 phosphorylation. We conclude
that the biological function of the peptoid might be linked to its
ability to interfere with the semaphorin/neuropilin interaction.
We also show that this peptoid reverses semaphorin-mediated
axon inhibition in an axotomy model, thereby promoting axon
regeneration.
RESULTS
Screening of a Combinatorial Library of Peptoids
to Identify Inhibitors of Sema3A
Previous studies have shown thatSema3Aacts as a chemorepul-
sive molecule for embryonic axons in several CNS and PNS
regions (Che´dotal et al., 1998; Messersmith et al., 1995; Paster-
kamp et al., 1998; Shepherd et al., 1996). In the hippocampus,
Sema3A causes strong chemorepulsion (Che´dotal et al., 1998).
In the present study, hippocampal tissue explants cultured over
2–3 days in vitro (DIV) gave rise to radial axons. In contrast,
when explants were exposed to aggregates of cells expressing
Sema3A, fibers displayed strong chemorepulsion and grew at
distal sites in nearly all cases (Figures 1 and 2B). To isolate
compounds thatmight interferewith Sema3A-induced chemore-
pulsion, we selected a simple, functional in vitro assay.We tested
products from a mixture-based combinatorial library composed
of trimers of N-alkylglycines (peptoids) (see Experimental Proce-
dures) (Humet et al., 2003). This library has two distinctive
features: (a) the use of the positional scanning format strategy
for its construction; and (b) the selection of diversity includes
the use of primary amines bearing an additional tertiary amino
moiety; the introduction of these amines affords peptoids con-
taining additional protonable fragments, which could comple-
ment the activity pattern and bioavailability of the library contents
(Humet et al., 2003). The general structure of the peptoids is
shown in Figure 1A. The library is organized into 66 mixtures,
each containing 484molecules, giving rise to a chemical diversity
of 10,648 individual compounds. Screening of the 66 mixtures in
the above assay identified the preferred position at the three
separate sites on the peptoid (R1, R2, and R3) (Figure 1A).
After screening the compounds in the peptoid library using
a Sema3A-induced chemorepulsion assay, we observed that
92.4% of the vials were inactive and that only five vial
compounds efficiently reversed the Sema3A effects on axonal
growth (Figure 1B). Thus, at the R1 position, the amino substit-
uent identified was 2-(N-methyl-20-pyrrolidinyl)ethyl (denoted
as amine 16); at the R2 position it was 2-(N-pyrrolidinyl)ethyl
(denoted as amine 6); and at the R3 position the substituents
were amine 16, 2-(N-morpholino)ethyl (denoted as amine 18)
and 2-(N,N-diethylamino)ethyl (denoted as amine 22). These
results gave an indication of the chemical composition of poten-
tially active molecules. We thus synthesized three individual
peptoids containing the different combinations of the above-
mentioned amines (i.e., N16-6-16C, N18-6-16C, and N22-6-
16C, Figures 1B and 1C) and we then assayed their activity.
These experiments in vitro demonstrated that the peptoid
N22-6-16C reversed Sema3A-induced chemorepulsion of
hippocampal axons most strongly. This compound was purified
by preparative reverse-phase high-performance liquid chroma-
tography and referred to as semaphorin-induced chemorepul-692 Chemistry & Biology 16, 691–701, July 31, 2009 ª2009 Elseviersion inhibitor (SICHI) (Figure 1C). Finally, we measured the
range of concentrations over which the peptoid is biologically
active without reducing cell viability. SICHI was effective at
between 0.00001 and 0.0002 mg/ml culture medium (Figure 2).
We also determined the IC-50 value (IC50 = 0.000039 mg/ml;
see Figure S1 available online). Surprisingly, higher peptoid
concentrations (up to 0.001 mg/ml) induced weaker effects
without apparent cell damage (Figure 2G; see Supplemental
Data).
Biological Activity of SICHI Is Specific for Sema3A
The findings reported above showed that SICHI blocks axonal
chemorepulsion inducedby recombinantSema3A.Weexamined
whether SICHI also blocked chemorepulsion caused by endog-
enous, tissue-expressed semaphorins. During hippocampal
development, Sema3A expression in the entorhinal cortex (EC)
A 
B
C
Figure 1. Strategy Followed for the Screening of the Library and
Identification of SICHI
(A) Structure of the library of peptoids.
(B) Inhibition of the chemorepulsion induced by Sema3A by the library peptoid
mixtures.
(C) Structure of the three defined peptoids identified after library deconvolution
as themost active inhibitors of the chemorepulsion induced by Sema3A. SICHI
is among these peptoids.Ltd All rights reserved
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Figure 2. SICHI Inhibits the Chemorepulsion Induced by Sema3A
(A) Hippocampal explants cocultured in collagen gels with control COS cells
exhibited redial axonal growth.
(B) Hippocampal axons exhibit strong chemorepulsion when cocultured with
aggregates of Sema3A-expressing cells.
(C–F) Sema3A-induced chemorepulsion is blockedwhen explants are cultured
in the presence of SICHI (0.00005–0.0001 mg/ml).
(G) Quantification of repulsion experiments: histograms showing the proximal/
distal values obtained, where P is the density of axons on the proximal side,
and D represents the density of axons in the distal quadrant. Note that chemo-
repulsion is impaired in the presence of different concentrations of SICHI.
Data represent the means and standard error of the mean (± SEM) of 24
explants from four independent experiments.Chemistry & Biology 1inhibits axonal growth, thereby preventing the entrance of these
axons to the EC (Che´dotal et al., 1998; Pasterkamp et al., 1998;
Pozas et al., 2001; Shepherd et al., 1996). We thus cocultured
at a distance explants from the entorhinal cortex (EC) and the
hippocampus in either the presence or absence of SICHI
(0.00001 and 0.0002 mg/ml). After 2–3 DIV the explants were fixed
with paraformaldehyde and a small crystal of the lipophilic tracer
1,10-dioctadecyl-3,3,30,30-tetramethylindocarbocyanine perchlo-
rate (DiI) was injected into the hippocampal explants. Fluores-
cence microscopic examination revealed that EC explants in-
hibited hippocampal axonal growth in nearly all the cocultures
(Figures 3A and 3C). In contrast, incubation with SICHI reversed
this effect, thereby yielding a radial pattern of axonal growth
(Figures 3B and 3C).
In addition to Sema3A, Sema 3F and netrin 1 are also axonal
chemorepellents (Alca´ntara et al., 2000; Che´dotal et al., 1998;
Colamarino and Tessier-Lavigne, 1995). We examined whether
SICHI was specific to Sema3A or whether it interfered with the
inhibition caused by these other chemorepellents. Similar assays
in vitro, in which hippocampal explants were exposed to
Sema3F-producing cells, showed that SICHI did not block this
chemorepulsion (Figures 3D–3F). Cerebellar explants exposed
to netrin 1-cell aggregates also showed similar patterns of che-
morepulsion both in the presence and in the absence of SICHI
(Figures 3G–3I). We thus conclude that SICHI blocks Sema3A-
induced chemorepulsion, but not that due to Sema 3F or netrin
1 and that the biological activity of SICHI is associated with the
Sema3A signaling pathway.
SICHI Inhibits Sema3A-Induced Growth-Cone Collapse
by Blocking GSK-3 Activation
An early step in axonal growth inhibition is growth-cone collapse
(Gallo and Letourneau, 2004). Under normal conditions, axonal
growth cones show large, triangular axonal endings bearing
numerous filopodia and lamellipodia (Figure S2A). In contrast,
most growth cones incubated with Sema3A for 30–45 min
showed round-tipped or ‘‘pencil-like’’ shapes. They also lacked
filopodia and lamellipodia, which is characteristic of axonal
growth-cone collapse (Figure S2b, see also Goshima et al.,
1995; He and Tessier-Lavigne, 1997; Jin and Strittmatter, 1997).
Sema3A-induced axonal growth-cone collapse was also
blocked by incubation with SICHI (0.0001–0.0002 mg/ml) (Figures
S2c–S2e). These results indicate that SICHI inhibits Sema3A-
induced chemorepulsion by blocking growth-cone collapse.
Sema3A-induced growth-cone collapse relies on a complex
signaling cascade that requires local activation of the kinase
GSK-3 in growth cones. The activity of GSK-3 depends on serine
phosphorylation, and Sema3A activates GSK-3 by decreasing
its phosphorylation (Bhat et al., 2000; Eickholt et al., 2002;
Hughes et al., 1993). To determine whether SICHI altered
GSK-3 phosphorylation, cultures were treated with Sema3A in
the presence of SICHI. Treatment with SICHI alone or SEAP
did not affect GSK-3 serine phosphorylation (Figures 4A and
4E). In contrast to controls, Sema3A induced a rapid decrease
in the local pool of P-Ser-GSK-3 (Figure 4B). However, in
**p < 0.01 (Student’s test). The p values ranged from 0.0035 to 0.000017.
Scale bars in A–F represent 50 mm.6, 691–701, July 31, 2009 ª2009 Elsevier Ltd All rights reserved 693
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Inhibitors of Sema3A Chemorepulsioncultures treated with SICHI, no such loss of P-Ser-GSK-3 was
induced by Sema3A (Figures 4C–4E). These results correlate
with the decreased number of collapsed growth cones observed
after SICHI incubation (Figure S2). We thus conclude that SICHI
interferes with the Sema3A-induced signaling cascade at the
level of growth cones.
SICHI Interferes with Sema3A Binding to Neuropilin
1/Plexin A1 Receptor Complex
The Np1/PlexA1 receptor complex mediates Sema3A binding
and axonal chemorepulsion (De Winter et al., 2002; Rohm
et al., 2000; Takahashi et al., 1999). To examinewhether the pep-
toid interferes with the binding of Sema3A to its receptors, we
transfected COS1 cells with cDNA vectors encoding Np1 and
PlexA1 and mapped Sema3A-AP binding by measuring alkaline
phosphatase activity (Rohm et al., 2000). In agreement with
previous studies (Rohm et al., 2000), the Np1/PlexA1 receptor
complex had higher affinity for Sema3A than for Np1 alone
(Figures 5A–5C), whereas PlexA1 alone showed no affinity for
Sema3A (Takahashi et al., 1999). Incubation with SICHI dramat-
ically decreased the binding of Sema3A-AP to both Np1/PlexA1
complexes and to Np1 alone (Figures 5D–5H). We conclude that
SICHI interferes with the binding of Sema3A to its endogenous
receptors.
SICHI Promotes Axonal Regeneration of Lesioned
Cortical Axons in Organotypic Cultures
The above results show that SICHI interferes with the effects of
Sema3A on developing axons. However, class III semaphorins,
like other axonal inhibitors, can inhibit regeneration in adult
nervous tissue (De Winter et al., 2002; Luo et al., 1993; Paster-
kamp et al., 1999; Shearer et al., 2003). We thus examined
whether SICHI promotes axonal regeneration. We used an
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Figure 3. SICHI Specifically Inhibits Che-
morepulsion Induced by Sema3A
(A–C) In control assays, hippocampal CA explants
coculturedwith entorhinal cortical explants showed
axonal repulsion (A). In the presence of SICHI
(0.0002 mg/ml), hippocampal CA axons grew radially
(B). Histogram showing the percentage of hippo-
campalexplantsshowingchemorepulsion incontrol
cocultures and after treatment with SICHI (C).
(D–F) Hippocampal explants have strong chemore-
pulsion after incubation with Sema3F-expressing
cells alone (D) or in combination with SICHI (E).
Histogram showing that Sema3F-induced chemo-
repulsion does not decrease after SICHI treat-
ment (F).
(G–I) Cocultures of postnatal EGL explants and
netrin-1-expressing cells show axonal repulsion in
both control assays (G) and after incubation with
SICHI (H). The histogram summarizes the percent-
ages of chemorepulsion (I).
Scale bar = 50 mm (A, B, D, E, G, H).
in vitro axotomy mode (cocultures with
entorhino-hippocampal organotypic sli-
ces) in which the cytoarchitecture of the
nervous tissue is preserved and the ento-
rhino-hippocampal pathway develops as
it does in vivo (Del Rio et al., 1997). In this system, after resection
of the EHP at 15 DIV, axons do not regenerate spontaneously
(Del Rio et al., 2002; Mingorance et al., 2005). This is therefore
a valid way to test potential promoters of neural regeneration
in vitro. First, we examined whether Sema3A or Np1 expression
was altered after axotomy. In situ hybridization experiments
showed that both Sema3A and Np1 transcripts were upregu-
lated soon after axotomy in the target hippocampus and in the
EC (Figure S3). Although expression of Sema3A remained high
7–10 days after axotomy, expression of Np1 mRNAs tended to
return to control levels in the EC (Figures S3B, S3C, S3E, and
S3F). Increased expression of Sema3A protein was corrobo-
rated by western blot after axotomy (Figures S3G and S3H).
These findings indicate that up-regulation of the Sema3A
signaling system is involved in the failure of the lesioned EHP
to regenerate. To assess this possibility, we used organotypic
slice cultures from a Sema3A knock-out mouse strain (Behar
et al., 1996). After 15 DIV, the EHP was resectioned as above
and slices were cultured for a further 15 days, after which the
EHP was traced by injections with the anterograde tracer
biocytin (Figure 6A). In agreement with previous studies (Del
Rio et al., 1997), very few axons regrew in controlwild-type slices
(Figures 6B, 6C, and 6F). The number of regenerating axons
increased in cocultures from Sema3A-deficient slices (Fig-
ures 6D–6F).
These findings show that genetic ablation of the Sema3A gene
promotes axonal regeneration, thereby validating the Sema3A
signaling pathway as a potential target for axonal repair. We
then postulated that interfering with Sema3A function by using
SICHI might allow regeneration of axotomized axons. Ento-
rhino-hippocampal cultures were established and axotomized
after 15 DIV as above. Slices were cultured for a further 15 days,
in which SICHI was added daily (see Del Rio et al., 2002) and the
694 Chemistry & Biology 16, 691–701, July 31, 2009 ª2009 Elsevier Ltd All rights reserved
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Inhibitors of Sema3A ChemorepulsionEHP was traced with biocytin (Figure 7). The results showed that
SICHI incubation at concentrations of 0.001–0.0002 mg/ml
increased 10-fold the number of regenerating axons growing
into the denervated hippocampus (Figures 7C and 7D).
Interestingly, many regenerating axons targeted the correct
termination layer, the stratum lacunosum-moleculare, and termi-
nated in growth-cone endings. As for embryonic explants, orga-
notypic slices appeared healthy after peptoid incubation
(Figure 7). The regeneration of axons following SICHI treatment
was similar to that observed in slices lacking Sema3A expression
(compare Figure 6 with Figure 7). Taken together, our data indi-
cate that Sema3A signaling is a valuable target for the promotion
of axonal regeneration. The peptoid SICHI might be used to
interfere with the biological actions of Sema3A in both devel-
oping and mature nervous tissue.
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Figure 4. Sema3A-Induced Changes in P-SerGSK3 Expression in
Growth Cones Are Blocked by SICHI
(A–D) P-SerGSK3 expression levels in growth cones incubated with control
medium (SEAP) (A), with Sema3A (B), with Sema3A and SICHI (0.0001 mg/ml
and 0.0002 mg/ml) (C and D). Incubation with SICHI blocks Sema3A-induced
loss of P-SerGSK3.
(E) Histogram showing quantification of P-SerGSK3 staining levels versus
rhodamine-phalloidin staining (labeled actin) in growth cones incubated under
different conditions. (Mean ± SEM, **p < 0.01; Student’s t test). The p values
ranged from 0.0072 to 0.0084.
Scale bars (A–D) = 10 mm.Chemistry & Biology 1DISCUSSION
Sema3A is a strong axonal chemorepellent that induces growth
cone collapse and might inhibit CNS regeneration (Fan and
Raper, 1995; Luo et al., 1993; Messersmith et al., 1995; Paster-
kamp et al., 1999; Shearer et al., 2003; De Winter et al., 2002).
Several strategies have been followed to reverse semaphorin
functions. These include pharmacological interference with
intracellular semaphorin signaling, and extrinsic attempts to
block the semaphorin/neuropilin interaction with soluble ecto-
domains of Np1-2 receptors (Goshima et al., 1999) or with a
complementary peptide (Williams et al., 2005), and the blockage
of the Np1-2 receptor with antibodies (Shearer et al., 2003).
Moreover, Hanbali et al. (2004) report a synthetic neurotrophic
compound that promotes cortical axon outgrowth in vitro in
the presence of Sema3A. However, neurotrophic factors sup-
plied in the culture medium might also promote axonal growth,
and it is difficult to discern whether these effects were due to
the increase in axonal outgrowth or to the inhibition of chemore-
pulsion. A compound isolated from the fermentation broth of
a fungal strain, Penicillum sp, reverses Sema3A-induced growth
cone collapse of dorsal root ganglion (DRG) neurons in vitro by
reducing receptor binding. Furthermore, this compound also
accelerates nerve regeneration in vivo in a rat model of olfactory
nerve axotomy (Kikuchi et al., 2003) and promotes regeneration
of lesioned cortico-spinal axons in the spinal cord (Kaneko et al.,
2006).
Here, we have developed a new strategy to isolate Sema3A
blockers by screening a peptoid combinatorial library. Peptoids
are a family of synthetic molecules with a wide variety of biolog-
ical activities, which renders them attractive for pharmaceutical
innovation (Simon et al., 1992; Zuckermann et al., 1992). The
various activities associated with N-trialkylglycines, together
with their proteolytic resistance and low-to-moderate toxicity
make them good candidates for hit identification. Peptoids
have been successfully used to identify high-affinity ligands for
membrane receptors of disruptors of macromolecular com-
plexes (Heizmann et al., 1999) and more recently, for protein-
protein interactions (Malet et al., 2006). Furthermore, N-trialkyl-
glycines have been used to identify anti-inflammatory, analgesic,
and neuroprotectant compounds with activity in vivo (Garcı´a-
Martı´nez et al., 2002; Montoliu et al., 2002; Planells-Cases
et al., 2002), and the structural simplicity of N-trialkylglycines
renders them labile to structural manipulation and, therefore,
lead-like property optimization.
A synthetic neurotrophic compound (tCFA15) counteracts the
inhibitory action of Sema3A and other myelin-associated inhibi-
tors (Hanbali et al., 2004). However, the reversion of Sema3A
effects induced by this compound was moderate, and its action
appears to be attributable to an overall neurotrophic potentiation
of axonal growth capabilities, rather than to the specific
blockade of Sema3A signaling. Another study has identified
peptides, mimicking the MAM Neuropilin domain and Sema3A
binding domain, that reduce growth-cone collapse at high
concentrations (Williams et al., 2005). However, as they are
susceptible to protease activity and the difficulties encountered
for introducing the adequate chemical modifications for con-
verting a peptide into a pharmacologically friendly molecule, it
seems difficult that these peptides could be used as therapeutic6, 691–701, July 31, 2009 ª2009 Elsevier Ltd All rights reserved 695
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Inhibitors of Sema3A Chemorepulsiontools. Like SICHI, SM-2162689 (xanthofulvin) appears to be fairly
specific for Sema3A signaling: it inhibits binding of Sema3A to its
receptors and promotes regeneration of axotomized neurons
(Kikuchi et al., 2003; Kaneko et al., 2006). However, from the
chemical point of view, xanthofulvin has a more complex struc-
ture than SICHI. This means that its availability would be limited
by microorganism production and further isolation and purifica-
tion. Moreover, the synthetic complexity of this molecule indi-
cates that an optimization programwould be difficult. Conversely,
trimers of N-alkylglycine, such as SICHI, can be synthesized in
amatter of hours and, interestingly for a hit compound, they offer
a broad variety of structural optimization strategies (e.g., Mon-
drago´n et al., 2008). For these reasons we believe that SICHI
not only constitutes an advantageous pharmacological tool for
studies on semaphorin inhibition, but also opens the field for
the future development of improved molecules.
The present study shows that SICHI consistently inhibits
Sema3A biological functions. Thus, the peptoid not only blocks
axonal chemorepulsion after exposure to recombinant Sema3A,
but also inhibits endogenous chemorepulsion (e.g., from the en-
torhinal cortex; see Figures 3A–3C). Furthermore, SICHI blocks
Sema3A-induced growth cone collapse. Finally, chemorepul-
sion induced by Sema 3F or netrin 1 was not affected by SICHI,
thereby reinforcing the specificity of the peptoid.
Our findings show that SICHI strongly decreases the binding
of recombinant Sema3A to the Np1/PlexA1 receptor complex
(He and Tessier-Lavigne, 1997; Kitsukawa et al., 1997; Kolodkin
et al., 1997), suggesting that SICHI interacts with these receptors.
The present data showing that SICHI blocks Sema3A-induced
GSK3 de-phosphorylation also support the idea that SICHI inter-
feres with the Sema3A signaling cascade (Eickholt et al., 2002;
Zhou et al., 2004). In this respect, the structure of SICHI is worth
mentioning. As shown in Figure 1, all three residues found on the
peptoid backbone contain an additional tertiary amino moiety. In
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Figure 5. SICHI Blocks Sema3A-AP Binding
to Np1/PlexA1 Receptor Complexes
Binding of Sema3A-AP to Np1/PlexA1 receptor
complexes expressed in COS cells; binding of
proteins was visualized using alkaline phospha-
tase histochemistry. Treatments with Sema3A.
The strong binding of Sema3A to Np1/PlexA1
receptor complexes (A and B) decreased dramat-
ically after incubation with SICHI (D and E).
(C and F) The low binding of Sema3A-AP with Np1
is not altered by incubation with SICHI.
(G) Control binding assay with SEAP on Np1/
PlexA1 expressing cells showing no histochemical
signals.
(H) Histogram representing Sema3A-AP-bound
under different conditions, expressed in arbitrary
units. (Mean ± SEM, *p < 0.05, **p < 0.01;
Student’s t test). The p values ranged from 0.020
to 1 3 109.
Scale bars represent 70 mm in A, C, D, F, G, and
35 mm in B and E.
physiological conditions, the molecule
would be expected to be extensively
protonated, which would suggest a role
of positive charges in the inhibitory activity.
This feature couldbeused in futureefforts tooptimize the structure
of SICHI. Our results showed that SICHI inhibits Sema3A chemo-
repulsion in a dose-dependent manner. We found that low
(0.00001 mg/ml) or high (0.01 mg/ml) doses did not affect responses
to Sema3A. This indicates that SICHI might be nontoxic, and thus
has potential therapeutic uses.
Axonal regeneration after injury to the CNS requires not
only the survival of injured neurons but also the functional re-es-
tablishment of synaptic connections. Axons in the adult mamma-
lian CNS exhibit poor regeneration after injury. The inhibitory
activity is mainly associated with components of CNS myelin
and molecules in the glial scar at the lesion site (He and Kopri-
vica, 2004; Schwab and Bartholdi, 1996; Silver and Miller,
2004). Recent studies have shown that three myelin proteins
(myelin-associated glycoprotein, Nogo-A, and oligodendrocyte
myelin glycoprotein) account for most of the inhibitory activity
of CNS myelin (Schwab and Bartholdi, 1996; Silver and Miller,
2004). The inhibitory activity of these proteins might bemediated
by common receptor complexes that consist of the ligand-
binding Nogo-66 receptor and its coreceptors p75/TROY and
Lingo-1 (Wang et al., 2002a, 2002b; Shao et al., 2005). However,
recent studies that genetically target these molecules have
shown only modest regeneration, suggesting that other inhibi-
tory signals contribute to the failure of axonal regrowth (Dimou
et al., 2006; Fry et al., 2007; Schnell and Schwab, 1990). The
present study, which shows that axotomy upregulates Sema3A
and Np1 expression in axotomized tissues, is consistent with
others (De Winter et al., 2002; Pasterkamp et al., 1998; Shearer
et al., 2003), and implicates semaphorins in the failure of the
adult CNS to regenerate. Indeed, our data demonstrate that
either genetic ablation of the Sema3A gene or functional
blockade of Sema3A/Np1 by incubation with the specific pep-
toid SICHI dramatically enhances axonal regeneration in an
in vitro organotypic model in vitro. Furthermore, SICHI promoted696 Chemistry & Biology 16, 691–701, July 31, 2009 ª2009 Elsevier Ltd All rights reserved
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regenerating entorhinal axons correctly targeted the stratum la-
cunosum-moleculare. Together, our findings indicate that SICHI
can not only block Sema3A in developing neurons, but also
promote axonal regeneration in the CNS.
SIGNIFICANCE
In the adult CNS, severed axons fail to regenerate beyond the
lesion site, in contrast to those in theperipheral or embryonic
nervous system. The failure of axon regeneration is attribut-
able to the environment encountered by injured axons,
including semaphorins. Sema3A is a strong axonal chemore-
pellent that induces growth cone collapse and might inhibit
CNS regeneration. By using a combinatorial screening
strategy,we identifiedastableN-alkylglycinepeptoid (SICHI)
that specifically blocks Sema3A biological functions, in-
cludingchemorepulsion, inboth thedevelopingand theadult
brain.Moreover, the biological activity of SICHI is specific for
Sema3A, because this compounddoes not affect Sema 3For
netrin 1 chemorepulsion. Moreover, SICHI application en-
hanced the regeneration of lesioned axons in slice cultures,
indicating that Sema3A signaling is a valuable target for the
promotion of axonal regeneration. Given the crucial involve-
ment of Sema3A in CNS regeneration (Kaneko et al., 2006)
and other human pathologies (Ieda et al., 2007), we suggest
that SICHI offers great potential for chemical optimization
(Mondrago´n et al., 2008). Thus, the development of confor-
mationally more restricted derivatives could lead to thera-
peutic approaches for diseases related to semaphorin
function and axonal regeneration (Koprivica et al., 2005).
EXPERIMENTAL PROCEDURES
Animals
OF1 embryos (E14–E15) and postnatal (P0–P6) mice (Criffa-Credo, Lyon,
France) were used. The mating day was considered embryonic day 0 (E0)
and the day of birth postnatal day 0 (P0). Mice were maintained and killed in
accordance with accepted animal care and use protocols. All procedures
involving animals and their care were approved by the Ethics Committee of
the University of Barcelona and were conducted according to institutional
guidelines that are in compliance with regional (Generalitat de Catalunya
decree 214/1997, DOGC 2450) and international (Guide for the Care and
Use of Laboratory Animals, National Institutes of Health, 85-23, 1985) laws
and policies.
Peptoid Library Screening
A library of peptoids containing 10,648 compounds was synthesized by using
the positional scanning format in solid phase (Humet et al., 2003). The library
was organized into 66 controlled mixtures and divided into three sublibraries
(OXX, XOX, and XXO, where O represents a defined diversity position and X
a pre-equilibrated mixture of all 22 commercially available amines used to
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Figure 6. Increased Regrowth of Entorhino-Hippocampal Fibers in
Organotypic Cultures from Sema3A Mutant Newborn Mice
(A) Schematic diagram illustrating the in vitro axotomy model used. The EHP
was axotomized at 15 DIV and traced with biocytin after an additional 15
day period.
(B and C) Organotypic cultures from Sema3A wild-type slices showing that
entorhinal axons do not regenerate after axotomy.
(D and E) Organotypic cultures from Sema3A mutant slices showing that
substantial entorhinal axons reinnervate specifically the stratum lacunosum-
moleculare (SLM) and molecular layer (ML), after in vitro axotomy. Panels C
and E are high magnifications of panels B and D.
(F) Histogram showing densities of regenerating axons under different condi-
tions. *p < 0.017, **p < 0.007; Student’s t test.
Scale bar represents 300 mm in A and C, and 60 mm in B and D.Chemistry & Biology 16, 691–701, July 31, 2009 ª2009 Elsevier Ltd All rights reserved 697
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resin (Rapp Polymer 0.7 mEq) the eight-step synthetic pathway involved the
initial release of the Fmoc-protecting group. Then successive steps of acyla-
tion with chloroacetyl chloride followed by the corresponding amination of
the chloromethyl intermediate using the particular primary amine, or the equi-
molecular mixture of the 22 amines, were performed, as appropriate. All these
reactions were carried out in duplicate. Finally, the products were released
from the resin by a trifluoroacetic acid/dichloromethane/water mixture,
solvents were evaporated, and the residues were lyophilized and dissolved
in 10% dimethyl sulfoxide at a concentration of 10 mg/ml for screening. We
used 1 mg/ml for each assay. The library was screened by assays on cultures
in collagen gel to identify active compounds.
Explant Cultures and Cocultures
Embryonic brains (E14–E16) were dissected out and sectioned at 250–350 mm
with a tissue chopper (Mickle Laboratory, UK). Selected slices were further
dissected with fine tungsten needles to isolate CA1 and CA3 areas of the
hippocampus proper, and the entorhinal cortex. Explants of CA1 and CA3
were confronted at a distance (200–600 mm) with COS1 cell aggregates trans-
fected with Sema3A-AP, sema3F-Ap, or netrin 1 cDNA containing vectors
(PsecTag1) (Che´dotal et al., 1998). Semaphorin expression in transfected cells
was tested by western blot. Explants and cell aggregates were embedded in
rat-tail collagen gel, and cultured in neurobasal medium supplemented with
L-glutamine, NaHCO3, D-glucose, and B27 supplement (GIBCOLife Technol-
ogies, Merelknge) for 72 hr in a 5% CO2, 95% humidly incubator at 37
C.
We then tested the 66 mixtures in the peptoid library. The final dimethyl sulf-
oxide (DMSO) concentration was below 1% and DMSO controls showed no
effect on explant cultures. Subsequent library deconvolution identified three
molecules that were individually synthesized and tested. Purified SICHI was
selected for further studies as the best inhibitor of these compounds. The
structure of SICHI was confirmed by analytical (high-resolution mass spec-
trometry) and spectroscopic (1H and 13C nuclear magnetic resonance)
methods, and details of the chemistry involved in the synthesis of this
compound will be published elsewhere. We added SICHI (10 ng/ml) to explant
cultures and cocultures.
Explants were fixed in 4% paraformaldehyde for 1 hr. Cocultures of the en-
torhinal cortex and hippocampuswere injected with a small crystal of lipophilic
tracer DiI (Molecular Probes) in CA1 and CA3. After 4–6 days in the dark, the
explants were examined under rhodamine fluorescent optics. In addition,
cocultures with aggregates of transfected COS cells were immunostained
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Figure 7. SICHI Promotes the Regeneration of the Perforant Pathway after Axotomy
(A–C) The entorhino-hippocampal pathway was axotomized as above, and the EHP was traced with biocytin 15 DIV after axotomy. In control conditions very few
axons regenerate (A). Incubation with SICHI dramatically increases the number of regenerating axons (B). High magnification of the boxed area shown in C,
showing robust regeneration of axotomized entorhinal axons.
(C and D) Histogram showing the densities of regenerating axons in different conditions (mean ± SEM). **p < 0.01; Student’s t test. The p values ranged from
0.00067 to 0.000022.
(E) Camera lucida drawing illustrating regenerating axons in a SICHI-treated axotomized culture. The red dashed line indicates the hippocampal fissure. Areas
CA1 and CA3 are shown; DG, dentate gyrus; S, subiculum; EC, entorhinal cortex.
Scale bars represent 300 mm in A, 60 mm in B, and 30 mm in C.698 Chemistry & Biology 16, 691–701, July 31, 2009 ª2009 Elsevier Ltd All rights reserved
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cocultured.
Collapse Assays
Glass coverslips (10 mm Ø) were coated with laminin (5 mg/ml, 1 hr) and poly-
D-lysine (10 mg/ml, 2 hr). After washing, CA1-3 explants were placed in the
same medium as above. After 2–3 DIV, their growth cones were visible.
Explants were incubated with 20% conditioned medium containing recombi-
nant Sema3A or control media, and including SICHI at the concentration
shown above, for 30–45 min. Cultures were then fixed in 4% paraformalde-
hyde, stained with phalloidin-rhodamine (Sigma, Poole, Dorset, UK), and
observed by confocal microscopy (Olympus). For quantification, a total of 50
growth cones were counted for each explant (a total of 216 explants were
used).
Binding Assay
We used AP-Sema3A as a ligand. This AP-semaphorin fusion protein was har-
vested from the conditioned media of transiently transfected COS cells.
Conditioned medium was concentrated using Ultrafree-15 30KD (Millipore).
COS cells were transfected with Np1 and PlexA1 in poly-L-lysine-coated
24-well plates. Cells transfected with the expression vector pBK-CMV were
used to measure nonspecific binding. We added SICHI with the ligand 48 hr
before transfection, except for control, at 37C. Cells were immediately fixed
in methanol at 80C for 5 min. Endogenous phosphatase was heat-in-
activated at 65C for 45 min. Bound alkaline phosphatase was detected by
precipitation of insoluble reaction product after incubation with 5-bromo-4-
chloro-3-indolyl phosphate (BCIP) 5 (18 mg/ml) and nitroblue tetrazolium (NBT)
6 (34 mg/ml) Sigma 7. The intensity of the reaction product was determined for
92 cells from digital images using an image analysis program.
Immunocytochemical Methods
Previous studies have identified a requirement for GSK3 activity in the Sema3A
signal transduction pathway. We used the collapse assay as described above
and explants were then fixed for immunocytochemical procedures. Mouse
monoclonal antibody against P- (Ser 21) GSK3 (Upstate Biotechnology)
(1:300) was incubated overnight at 4C. Bound antibody was visualized using
fluorescein goat-antimouse Alexa fluor (1:300, Molecular Probes) for 2 hr at
room temperature, and phalloidin. A total of 2500 growth coneswere analyzed.
In Situ Hybridization
In situ hybridization was performed on free-floating sections, as described
elsewhere (Alca´ntara et al., 1998). Sections were permeabilized in 0.2% Triton
X-100 (15 min), treated with 2% H2O2 (15 min), deproteinized with 0.2 N HCl
(10 min), fixed in 4% PFA (10 min), and blocked in 0.2% glycine (5 min). There-
after, sections were prehybridized at 60C for 3 hr in a solution containing 50%
formamide, 10% dextran sulfate, 5X Denhardt’s solution, 0.62 M NaCl, 10 mM
EDTA, 20 mMPipes (pH 6.8), 50 mMDTT, 250 mg/ml yeast t-RNA, and 250 mg/
ml denatured salmon sperm DNA. Sema3A (Messersmith et al., 1995) andNp1
(He and Tessier-Lavigne, 1997) riboprobes were labeled with digoxigenin-d-
UTP (Boehringer-Mannheim) by in vitro transcription. Antisense Sema3A and
Np1 riboprobes were transcribed using T3 polymerase (Ambion) and the cor-
responding sense riboprobes were obtained using T7 polymerase (Ambion).
Labeled antisense cRNA was added to the prehybridization solution (250–
500 ng/ml) and hybridization was carried out at 60C overnight. Sections
were then washed in 2XSSC (30 min, room temperature), digested with
20 mg/ml RNase A (37C, 1 hr), washed in 0.5XSSC/50% formamide (4 hr,
55C) and in 0.1XSSC/0.1% sarcosyl (1 hr, 60C). After rinsing in Tris-buffered
saline/0.1% Tween 20 (15 min), sections were blocked in 10% normal goat
serum (2 hr) and incubated overnight with an alkaline phosphatase-conjugated
antibody to digoxigenin (Boehringer-Mannheim, 1:2000). After washing,
sections were developed with NBT and BCIP (Life Technologies), mounted
on gelatinized slides, and coverslipped with Mowiol.
Control hybridizations, including hybridization with sense digoxigenin-
labeled riboprobes or RNase A digestion before the hybridization, prevented
alkaline phosphatase staining above background levels.Chemistry & Biology 1Organotypic Slice Cultures and Regeneration Assays
OF1 mice and mutant mice, generated by replacement of the first coding exon
of the Sema3A gene with a neo cassette (Behar et al., 1996), were used. Ento-
rhino-hippocampal organotypic slice cocultures were prepared as described
by Stoppini et al. (1991). Two weeks after explantation, the entorhino-hippo-
campal connections were axotomized by cutting the cocultures from the rhinal
fissure to the ventricular side along the entire entorhino-hippocampal interface
with a tungsten knife (Del Rio et al., 2002). SICHI was administered thereafter
every 48 hr for 2 weeks after the lesion (0.001, 0.002, 0.01 mg/ml), in 38 lesioned
cultures. After 15 of treatment, the regeneration of the entorhino-hippocampal
connection was accessed/assessed by injecting a small crystal of Biocytin
(Sigma) into the entorhinal cortex. Biocytin-labeled cultures were fixed with
paraformaldehyde and processed as described elsewhere (Del Rio et al.,
1996, 1997). For quantification, the number of biocytin-labeled fibers that
crossed a 400 mm segment located at a distance of 75–80 mm from the lesion
in the hippocampus, parallel to the lesion interphase, was counted for consec-
utive sections from each culture (403 oil immersion objective).
Statistics
Data are expressed as mean and standard error of the mean. Statistical signif-
icance was evaluated using the Student’s t test.
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Discussion, Supplemental Experi-
mental Procedures, and three figures and can be found with this article online
at http://www.cell.com/chemistry-biology/S1074-5521(09)00173-2.
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